148 related articles for article (PubMed ID: 36173048)
1. A Systematic Review of the Therapeutic Potential of Resveratrol During Colorectal Cancer Chemotherapy.
Wu XY; Zhai J; Huan XK; Xu WW; Tian J; Farhood B
Mini Rev Med Chem; 2023; 23(10):1137-1152. PubMed ID: 36173048
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of the therapeutic effects of resveratrol in combination with 5-fluorouracil during colorectal cancer treatment: with a special focus on the oxidant, apoptotic, and anti-inflammatory activities.
Moutabian H; Majdaeen M; Ghahramani-Asl R; Yadollahi M; Gharepapagh E; Ataei G; Falahatpour Z; Bagheri H; Farhood B
Cancer Cell Int; 2022 Apr; 22(1):142. PubMed ID: 35366874
[TBL] [Abstract][Full Text] [Related]
3. The Radiosensitizing Potentials of Silymarin/Silibinin in Cancer: A Systematic Review.
Gupta J; Turki Jalil A; Al-Hawraa Riyad Muedii Z; Aminov Z; Alsaikhan F; Ramírez-Coronel A; Ramaiah P; Farhood B
Curr Med Chem; 2023 Oct; ():. PubMed ID: 37921180
[TBL] [Abstract][Full Text] [Related]
4. A Systematic Review of the Potential Chemoprotective Effects of Resveratrol on Doxorubicin-Induced Cardiotoxicity: Focus on the Antioxidant, Antiapoptotic, and Anti-Inflammatory Activities.
Hu LF; Lan HR; Li XM; Jin KT
Oxid Med Cell Longev; 2021; 2021():2951697. PubMed ID: 34471463
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol as sensitizer in colorectal cancer plasticity.
Brockmueller A; Sajeev A; Koklesova L; Samuel SM; Kubatka P; Büsselberg D; Kunnumakkara AB; Shakibaei M
Cancer Metastasis Rev; 2024 Mar; 43(1):55-85. PubMed ID: 37507626
[TBL] [Abstract][Full Text] [Related]
6. The clinical effectiveness and cost-effectiveness of cetuximab (mono- or combination chemotherapy), bevacizumab (combination with non-oxaliplatin chemotherapy) and panitumumab (monotherapy) for the treatment of metastatic colorectal cancer after first-line chemotherapy (review of technology appraisal No.150 and part review of technology appraisal No. 118): a systematic review and economic model.
Hoyle M; Crathorne L; Peters J; Jones-Hughes T; Cooper C; Napier M; Tappenden P; Hyde C
Health Technol Assess; 2013 Apr; 17(14):1-237. PubMed ID: 23547747
[TBL] [Abstract][Full Text] [Related]
7. Recent update on the protective potentials of resveratrol against cisplatin-induced ototoxicity: a systematic review.
Alsaikhan F; Jasim SA; Margiana R; Opulencia MJC; Yasin G; Hammid AT; Nasretdinova MT; Mahdi AB; Farhood B; Abedi-Firouzjah R; Jamialahmadi T; Sahebkar A
Curr Med Chem; 2023 Jul; ():. PubMed ID: 37491852
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol potentiates the anti-tumor effects of rapamycin in papillary thyroid cancer: PI3K/AKT/mTOR pathway involved.
Bian P; Hu W; Liu C; Li L
Arch Biochem Biophys; 2020 Aug; 689():108461. PubMed ID: 32531316
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol as Chemosensitizer Agent: State of Art and Future Perspectives.
Cocetta V; Quagliariello V; Fiorica F; Berretta M; Montopoli M
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669559
[TBL] [Abstract][Full Text] [Related]
12. Roscovitine synergizes with conventional chemo-therapeutic drugs to induce efficient apoptosis of human colorectal cancer cells.
Abaza MS; Bahman AM; Al-Attiyah RJ
World J Gastroenterol; 2008 Sep; 14(33):5162-75. PubMed ID: 18777593
[TBL] [Abstract][Full Text] [Related]
13. Bioactive Peptides Sensitize Cells to Anticancer Effects of Oxaliplatin in Human Colorectal Cancer Xenografts in Nude Mice.
Li X; Xia L; Ouyang X; Suyila Q; Su L; Su X
Protein Pept Lett; 2019; 26(7):512-522. PubMed ID: 30950338
[TBL] [Abstract][Full Text] [Related]
14. Resveratrol in Cancer Therapy: From Stimulation of Genomic Stability to Adjuvant Cancer Therapy: A Comprehensive Review.
Amini P; Moazamiyanfar R; Dakkali MS; Khani A; Jafarzadeh E; Mouludi K; Khodamoradi E; Johari R; Taeb S; Najafi M
Curr Top Med Chem; 2023; 23(8):629-648. PubMed ID: 36239730
[TBL] [Abstract][Full Text] [Related]
15. The Complex Composition of Trans-resveratrol, Quercetin, Vitamin E and Selenium Inhibits the Growth of Colorectal Carcinoma.
Czapla J; Drzyzga A; Matuszczak S; Pilny E; Cichoń T; Stojecki K; Smolarczyk R
Anticancer Res; 2022 Oct; 42(10):4763-4772. PubMed ID: 36191991
[TBL] [Abstract][Full Text] [Related]
16. The clinical effectiveness and cost-effectiveness of cetuximab (review of technology appraisal no. 176) and panitumumab (partial review of technology appraisal no. 240) for previously untreated metastatic colorectal cancer: a systematic review and economic evaluation.
Huxley N; Crathorne L; Varley-Campbell J; Tikhonova I; Snowsill T; Briscoe S; Peters J; Bond M; Napier M; Hoyle M
Health Technol Assess; 2017 Jun; 21(38):1-294. PubMed ID: 28682222
[TBL] [Abstract][Full Text] [Related]
17. The role of curcumin/curcuminoids during gastric cancer chemotherapy: A systematic review of non-clinical study.
Najafi M; Mortezaee K; Rahimifard M; Farhood B; Haghi-Aminjan H
Life Sci; 2020 Sep; 257():118051. PubMed ID: 32634426
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol: An overview of its anti-cancer mechanisms.
Elshaer M; Chen Y; Wang XJ; Tang X
Life Sci; 2018 Aug; 207():340-349. PubMed ID: 29959028
[TBL] [Abstract][Full Text] [Related]
19. Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations.
Cerea G; Vaghi M; Ardizzoia A; Villa S; Bucovec R; Mengo S; Gardani G; Tancini G; Lissoni P
Anticancer Res; 2003; 23(2C):1951-4. PubMed ID: 12820485
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol induces chemosensitization to 5-fluorouracil through up-regulation of intercellular junctions, Epithelial-to-mesenchymal transition and apoptosis in colorectal cancer.
Buhrmann C; Shayan P; Kraehe P; Popper B; Goel A; Shakibaei M
Biochem Pharmacol; 2015 Nov; 98(1):51-68. PubMed ID: 26310874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
